Meta-analysis of 3 RCTs (N=355) in people who vape daily: varenicline increased 7-day point prevalence abstinence (RR 2.28) and continuous abstinence (RR 2.71) vs placebo, with more nausea, insomnia and vivid dreams; dropout did not differ.
Meta-analysisn = 355
Srisurapanont et al. Varenicline for e-cigarette (vaping) cessation: Systematic review and meta-analysis of randomized controlled trials